Patents by Inventor Jaron Matthew Acker

Jaron Matthew Acker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: D1061594
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: February 11, 2025
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1064285
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: February 25, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Brian McCormack, Michael McAtamney, Jaron Matthew Acker
  • Patent number: D1069817
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: April 8, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1086469
    Type: Grant
    Filed: October 24, 2024
    Date of Patent: July 29, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Brian McCormack, Michael McAtamney, Jaron Matthew Acker
  • Patent number: D1087129
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: August 5, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1092732
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: September 9, 2025
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1108635
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: January 6, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Michael McAtamney, Jaron Matthew Acker, Curtis Irwin, Jake Martyn Goodwin
  • Patent number: D1120338
    Type: Grant
    Filed: June 17, 2025
    Date of Patent: March 24, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Brian McCormack, Michael McAtamney, Jaron Matthew Acker
  • Patent number: D1125541
    Type: Grant
    Filed: August 4, 2025
    Date of Patent: May 5, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1125542
    Type: Grant
    Filed: August 4, 2025
    Date of Patent: May 5, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1125543
    Type: Grant
    Filed: September 5, 2025
    Date of Patent: May 5, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1126242
    Type: Grant
    Filed: October 24, 2024
    Date of Patent: May 12, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1135921
    Type: Grant
    Filed: October 10, 2024
    Date of Patent: July 21, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1137678
    Type: Grant
    Filed: October 16, 2025
    Date of Patent: July 28, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Michael McAtamney, Jaron Matthew Acker, Curtis Irwin, Jake Martyn Goodwin
  • Patent number: D1146020
    Type: Grant
    Filed: August 4, 2025
    Date of Patent: September 1, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1147367
    Type: Grant
    Filed: October 16, 2025
    Date of Patent: September 8, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Michael McAtamney, Jaron Matthew Acker, Curtis Irwin, Jake Martyn Goodwin
  • Patent number: D1154655
    Type: Grant
    Filed: January 30, 2025
    Date of Patent: October 20, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1156436
    Type: Grant
    Filed: October 9, 2025
    Date of Patent: November 3, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1156437
    Type: Grant
    Filed: October 9, 2025
    Date of Patent: November 3, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1156456
    Type: Grant
    Filed: October 9, 2025
    Date of Patent: November 3, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva